Previous 10 | Next 10 |
home / stock / seovf / seovf news
Vancouver, British Columbia--(Newsfile Corp. - October 17, 2019) - Sernova Corp. (TSXV: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical stage regenerative medicine company, has reported findings that further validate Cell Pouch™ and therapeutic cell performance in Type-1 diabetes. The Cell P...
(via TheNewswire) Findings further validate Cell Pouch and therapeutic cell performance in Type-1 diabetes LONDON, ONTARIO - TheNewswire - October 16, 2019 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, is pleased to...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 17, 2019 - Sernova Corp. (TSXV:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announces that it has renewed the engagement of Frontier Flex, an investor relations (IR) and marketi...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 10, 2019 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announces it has completed on Monday a non-brokered private placement of $4.685 million, pursuant to which Sernova issued a total of 23,422,822 Units in...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 3, 2019 - Sernova Corp. (TSXV:SVA) (FSE:PSH) (OTC:SEOVF), a clinical-stage regenerative medicine company, is pleased to announce that it has completed a second closing of $2,251,065 of its non-brokered private ...
(via TheNewswire) Offering Increased to $3,500,000 LONDON, ONTARIO - TheNewswire - August 19, 2019 - Sernova Corp. (TSXV:SVA) (FSEPSH) (OTC:SEOVF), a clinical-stage regenerative medicine company, is pleased to announce that it has completed a first closing of $2,3...
(via TheNewswire) L ondon, Ontario - TheNewswire - July 25, 2019 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announces a proposed private placement (the "Offering") of up to $3 million in units (the "Units") of the Company at a price of $0.20 per Unit includin...
(via TheNewswire) CEO to participate in conference call with Sernova Shareholders on July 18 at 10:00 am (EDT) LONDON, ONTARIO - TheNewswire - July 17, 2019 - Sernova Corp. (TSXV:SVA) (FSE:PSH) (OTCQB:SEOVF), a clinical-stage regenerative medicine company today an...
(via TheNewswire) Sernova's Cell Pouch (TM) with transplanted islet cells reached primary safety measurements and clinically significant efficacy outcomes including glucose-stimulated C-peptide and the release of insulin in the first patient transplanted LONDON, ONTAR...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 27, 2019 - Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF), a clinical-stage regenerative medicine company is pleased to announce that Dr. Piotr Witkowski, Director of Pancreatic, and Islet Transplant Program at the University ...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...